Alejandro Chade

5.9k total citations · 1 hit paper
113 papers, 4.6k citations indexed

About

Alejandro Chade is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Surgery. According to data from OpenAlex, Alejandro Chade has authored 113 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Pulmonary and Respiratory Medicine, 33 papers in Nephrology and 25 papers in Surgery. Recurrent topics in Alejandro Chade's work include Renal and Vascular Pathologies (54 papers), Chronic Kidney Disease and Diabetes (25 papers) and Aortic aneurysm repair treatments (24 papers). Alejandro Chade is often cited by papers focused on Renal and Vascular Pathologies (54 papers), Chronic Kidney Disease and Diabetes (25 papers) and Aortic aneurysm repair treatments (24 papers). Alejandro Chade collaborates with scholars based in United States, Italy and Canada. Alejandro Chade's co-authors include Lilach O. Lerman, Amir Lerman, Claudio Napoli, Martin Rodriguez‐Porcel, James D. Krier, Xiang-Yang Zhu, Xiangyang Zhu, Joseph P. Grande, Erik L. Ritman and Gene L. Bidwell and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Circulation Research.

In The Last Decade

Alejandro Chade

110 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Animal Models of Hypertension: A Scientific Statement From the American Heart Association

2019 228 citations Lilach O. Lerman, Alejandro Chade et al. Hypertension profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alejandro Chade United States	41	1.8k	1.0k	999	989	976	113	4.6k
Martin Rodriguez‐Porcel United States	36	1.0k 0.5×	773 0.8×	785 0.8×	838 0.8×	350 0.4×	94	3.4k
Alfonso Eirin United States	45	1.7k 0.9×	676 0.7×	2.9k 2.9×	1.2k 1.2×	1.2k 1.3×	161	6.3k
James D. Krier United States	30	1.2k 0.7×	476 0.5×	592 0.6×	689 0.7×	450 0.5×	60	2.7k
Fujío Numano Japan	43	3.3k 1.8×	959 0.9×	797 0.8×	1.1k 1.2×	957 1.0×	230	6.1k
Charles D. Collard United States	36	710 0.4×	1.9k 1.8×	631 0.6×	1.8k 1.8×	355 0.4×	109	5.0k
Christos Chatziantoniou France	41	647 0.4×	1.3k 1.2×	1.4k 1.4×	510 0.5×	940 1.0×	133	4.2k
Wolfgang Schneider Germany	41	893 0.5×	846 0.8×	1.3k 1.3×	930 0.9×	393 0.4×	186	5.2k
Jean‐Luc Dubois‐Randé France	47	1.5k 0.8×	3.6k 3.5×	1.7k 1.7×	1.1k 1.1×	374 0.4×	154	6.6k
Atsushi Shioi Japan	36	648 0.4×	712 0.7×	1.5k 1.5×	773 0.8×	2.2k 2.3×	97	5.3k
Noriaki Yorioka Japan	30	623 0.3×	369 0.4×	949 0.9×	648 0.7×	2.0k 2.1×	176	3.9k

Countries citing papers authored by Alejandro Chade

Since Specialization

Citations

This map shows the geographic impact of Alejandro Chade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Chade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Chade more than expected).

Fields of papers citing papers by Alejandro Chade

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Chade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Chade. The network helps show where Alejandro Chade may publish in the future.

Co-authorship network of co-authors of Alejandro Chade

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Chade. A scholar is included among the top collaborators of Alejandro Chade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Chade. Alejandro Chade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chade, Alejandro, et al.. (2025). Renal Single-Nuclear Transcriptomics Identifies Novel Therapeutic Targets in a Preclinical Model of CKD. Kidney360. 6(10). 1657–1670. 1 indexed citations

Chade, Alejandro, et al.. (2024). Expanding landscape of coronary microvascular disease in co-morbid conditions: Metabolic disease and beyond. Journal of Molecular and Cellular Cardiology. 192. 26–35. 2 indexed citations

Chade, Alejandro & Gene L. Bidwell. (2022). Novel Drug Delivery Technologies and Targets for Renal Disease. Hypertension. 79(9). 1937–1948. 9 indexed citations

Chade, Alejandro & Alfonso Eirin. (2022). Pathophysiology of CKD-Left Ventricular Diastolic Dysfunction: Role of Renal TNF-α and IL-6 Inflammatory Signaling. Journal of the American Society of Nephrology. 33(11S). 871–871.

Chade, Alejandro, Jason Engel, Michael E. Hall, Alfonso Eirin, & Gene L. Bidwell. (2021). Intrarenal modulation of NF-κB activity attenuates cardiac injury in a swine model of CKD: a renal-cardio axis. American Journal of Physiology-Renal Physiology. 321(4). F411–F423. 13 indexed citations

Chade, Alejandro, et al.. (2020). Molecular targeting of renal inflammation using drug delivery technology to inhibit NF-κB improves renal recovery in chronic kidney disease. American Journal of Physiology-Renal Physiology. 319(1). F139–F148. 16 indexed citations

Spradley, Frank T., Ying Ge, Joey P. Granger, & Alejandro Chade. (2020). Utero-placental vascular remodeling during late gestation in Sprague-Dawley rats. Pregnancy Hypertension. 20. 36–43. 7 indexed citations

Engel, Jason, et al.. (2020). Recovery of Renal Function following Kidney-Specific VEGF Therapy in Experimental Renovascular Disease. American Journal of Nephrology. 51(11). 891–902. 19 indexed citations

Engel, Jason, et al.. (2019). Biopolymer-delivered vascular endothelial growth factor improves renal outcomes following revascularization. American Journal of Physiology-Renal Physiology. 316(5). F1016–F1025. 18 indexed citations

10.

Mahdi, Fakhri, Alejandro Chade, & Gene L. Bidwell. (2019). Utilizing a Kidney-Targeting Peptide to Improve Renal Deposition of a Pro-Angiogenic Protein Biopolymer. Pharmaceutics. 11(10). 542–542. 14 indexed citations

11.

Chade, Alejandro, et al.. (2017). Systemic biopolymer-delivered vascular endothelial growth factor promotes therapeutic angiogenesis in experimental renovascular disease. Kidney International. 93(4). 842–854. 32 indexed citations

12.

Bidwell, Gene L., et al.. (2016). A kidney-selective biopolymer for targeted drug delivery. American Journal of Physiology-Renal Physiology. 312(1). F54–F64. 61 indexed citations

13.

Herrmann, Sandra M., Ardan M. Saguner, Ana I. Flores, et al.. (2013). Primary Proteasome Inhibition Results in Cardiac Dysfunction. European Journal of Heart Failure. 15(6). 614–623. 61 indexed citations

14.

Herrmann, Sandra M., Ardan M. Saguner, Daniele Versari, et al.. (2007). Chronic Proteasome Inhibition Contributes to Coronary Atherosclerosis. Circulation Research. 101(9). 865–874. 86 indexed citations

15.

Zhu, Xiang-Yang, Michael D. Bentley, Alejandro Chade, et al.. (2007). Early changes in coronary artery wall structure detected by microcomputed tomography in experimental hypercholesterolemia. American Journal of Physiology-Heart and Circulatory Physiology. 293(3). H1997–H2003. 15 indexed citations

16.

Daghini, Elena, Andrew N. Primak, Alejandro Chade, et al.. (2007). Evaluation of Porcine Myocardial Microvascular Permeability and Fractional Vascular Volume Using 64-Slice Helical Computed Tomography (CT). Investigative Radiology. 42(5). 274–282. 34 indexed citations

17.

Chade, Alejandro, David Brosh, Stuart T. Higano, et al.. (2006). Mild renal insufficiency is associated with reduced coronary flow in patients with non-obstructive coronary artery disease. Kidney International. 69(2). 266–271. 87 indexed citations

18.

Chade, Alejandro, James D. Krier, Stephen C. Textor, Amir Lerman, & Lilach O. Lerman. (2006). Endothelin-A Receptor Blockade Improves Renal Microvascular Architecture and Function in Experimental Hypercholesterolemia. Journal of the American Society of Nephrology. 17(12). 3394–3403. 35 indexed citations

19.

Chade, Alejandro, Patricia J.M. Best, Martin Rodriguez‐Porcel, et al.. (2003). Endothelin-1 receptor blockade prevents renal injury in experimental hypercholesterolemia. Kidney International. 64(3). 962–969. 49 indexed citations

20.

Wilson, Samuel H., Alejandro Chade, Ariel E. Feldstein, et al.. (2003). Lipid-lowering-independent effects of simvastatin on the kidney in experimental hypercholesterolaemia. Nephrology Dialysis Transplantation. 18(4). 703–709. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact